arrow
T

Takashi Kuwayama

tokyo metropolitan cancer & infectious diseases center komagome hospital
H指数:12
被引数:646

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD

甲磺酸艾瑞布林与多西他赛或紫杉醇联合曲妥珠单抗和帕妥珠单抗作为HER2阳性局部晚期或转移性乳腺癌的一线治疗的疗效和安全性:JBCRG-M06/EMERALD研究的更新亚组分析

2026-07-080
PRE
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study
2023-10-211
PRE
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients
2023-03-173
PRE
Copy number alteration is an independent prognostic biomarker in triplenegative breast cancer patients
2023-03-010
PRE
Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)
2021-04-036
OAAI
Meta-analysis of nanoparticle albumin-bound paclitaxel (Nab-PTX) used as a neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01)
2020-02-150
PRE
Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women
2017-02-2511
PREAI